Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-25-056295
Filing Date
2025-04-21
Accepted
2025-04-21 16:12:38
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A scph-defa14a-2025_v2.htm DEFA14A 30539
2 GRAPHIC img62454858_0.jpg GRAPHIC 504242
3 GRAPHIC img62454858_1.jpg GRAPHIC 355113
  Complete submission text file 0000950170-25-056295.txt   1214696
Mailing Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803
Business Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

EIN.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38293 | Film No.: 25853281
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)